Rhesus Isoimmunization: Late-onset Hemolytic Disease of the Newborn Without Jaundice
نویسندگان
چکیده
منابع مشابه
Rhesus Isoimmunization and Therapeutic
SIRy-Mr. W. L. Whitehouse (21 June, p. 759), like myself' and many others, again calls attention to the potential dangers of rhesus isoimmunization in therapeutic abortion. He asks that the extent of this problem be further and scientifically investigated. There are, in fact, one or two further facets to be considered. Firstly, all of us are aware of the numbers of women whose first continuing ...
متن کاملRhesus isoimmunization after abortion.
Out of 177 Rh(D)-negative patients studied, 96 were successfully followed-up after spontaneous or therapeutic abortion. Rh antibodies were detected by the indirect Coombs test in two patients and by an enzyme technique only in a further seven, an overall incidence of 9.4%.The prophylactic use of anti-D immunoglobulin is now recommended for Rh-negative non-immunized patients undergoing abortion,...
متن کاملHemolytic Disease of the Newborn
Hemolytic disease of the newborn (HDN), with high potential for increased fetal loss is less common now, due to the universal screening for iso-sensitization and also because of appropriate use of antenatal anti-RhD antibody prophylaxis. There are other non-RhD antibodies that can cause HDN. In US, we occasionally encounter a highly sensitized fetus with significant morbidity and mortality. In ...
متن کاملNeonatal jaundice due to Rhesus and AB isoimmunization and frequency of these antigens in Pakistani mothers.
Frequency of Rhesus and ABO blood groups was determined in 3012 mothers. The blood groups in order of frequency were B, O, A and AB. Only 6.2% mothers were rhesus negative. ABO haemolytie disease of the newborn (HDN) accounted for 15.7% and Rh-HDN for 12.7% of 306 neonate admitted with Jaundice. No significant difference was found in two groups when levels of serum bilirubin, exchange transfusi...
متن کاملImmunologic Basis and Immunoprophy-laxis of RhD Induced Hemolytic Disease of the Newborn (HDN)
RhD antigen is the most immunogenic and clinically significant antigen of red blood cells after ABO system. It has historically been associated with hemolytic disease of the newborn (HDN) which is now routinely prevented by the administration of polyclonal anti-D immunoglobulin. This management of HDN has proven to be one of the most successful cases of prophylactic treatment based on antibody ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2020
ISSN: 2168-8184
DOI: 10.7759/cureus.6559